UMIN-CTR History

BACK TOP
UMIN-CTR English Home Glossary (Simple) FAQ Search clinical trials

Name:
UMIN ID:

Unique ID issued by UMIN UMIN000001857
Receipt No. R000002236
Scientific Title A phase I study of cancer vaccine with NY-ESO-1 overlapping peptides in patients with advanced cancers expressing NY-ESO-1 antigen
Date of disclosure of the study information 2009/04/10
Last modified on 2016/10/12 10:43:34

No. Disposal Last modified on Item of update
1 Insert 2009/04/07 10:06:25
2 Update 2010/04/07 10:11:06 Recruitment status
3 Update 2010/08/23 13:13:27 Recruitment status
4 Update 2010/10/08 08:28:24 Recruitment status
5 Update 2012/04/08 08:53:15 Date analysis concluded
6 Update 2012/04/08 08:54:28 Post marketing survey by drug manufacture etc., specified by Japanese law.
7 Update 2012/05/08 10:52:53 Recruitment status
8 Update 2013/04/07 09:32:13 Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
Publication of results
Results
Results
9 Update 2013/10/07 10:16:27 Email
Homepage URL
Institutions
10 Update 2015/10/07 09:41:15 Key inclusion criteria
11 Update 2016/04/07 09:03:25 Name of primary sponsor
Institute
Department
Organization
12 Update 2016/10/12 10:43:34 Recruitment status
Publication of results
URL related to results and publications
Results
Results


Contact us.